826998

Bell Pharmaceuticals, Inc — FEI 2123499

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 5, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Belle Plaine, MN (United States)

Citations

IDCFRDescription
150521 CFR 211.122(d)Label storage access limited to authorized personnel
200921 CFR 211.188Prepared for each batch, include complete information
8935FDCA 760(b)(1)Failure of responsible person to report AE (non-RX Drug)